The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Peptide therapeutics: current status and future directions
Open accessAbstract
Peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated. Consequently, there is an increased interest in peptides in pharmaceutical research and development (R&D), and approximately 140 peptide therapeutics are currently being evaluated in clinical trials. Given that the low-hanging fruits in the form of obvious peptide targets have already been picked, it has now become necessary to explore new routes beyond traditional peptide design. Examples of such approaches are multifunctional and cell penetrating peptides, as well as peptide drug conjugates. Here, we discuss the current status, strengths, and weaknesses of peptides as medicines and the emerging new opportunities in peptide drug design and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stability of Protein Pharmaceuticals: An Update
Manning, M. C., Chou, D. K., Murphy, B. M., Payne, R. W., & Katayama, D. S. (2010) · Pharmaceutical Research · doi:10.1007/s11095-009-0045-6 · Cited by 1,098
Future directions for peptide therapeutics development
Kaspar, A. A., & Reichert, J. M. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.011 · Cited by 750
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Hamley, I. W. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700861 · Cited by 618
The uses and properties of PEG-linked proteins.
Delgado, C., Francis, G. E., & Fisher, D. (1992) · PubMed · Cited by 420
Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Pocai, A., Carrington, P. E., Adams, J. R., Wright, M., Eiermann, G., Zhu, L., Du, X., Petrov, A., Lassman, M. E., Jiang, G., et al. (2009) · Diabetes · doi:10.2337/db09-0278 · Cited by 409
The Human Intestinal Microbiome: A New Frontier of Human Biology
Hattori, M., & Taylor, T. D. (2009) · DNA Research · doi:10.1093/dnares/dsn033 · Cited by 281
Peptide-based radiopharmaceuticals and cytotoxic conjugates: Potential tools against cancer
Okarvi, S. M. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.07.017 · Cited by 163
Neuroactive Peptides as Putative Mediators of Antiepileptic Ketogenic Diets
Giordano, C., Marchiò, M., Timofeeva, E., & Biagini, G. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00063 · Cited by 150
Antimicrobial peptides and proteins in mycobacterial therapy: Current status and future prospects
Padhi, A., Sengupta, M., Sengupta, S., Roehm, K. H., & Sonawane, A. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.03.011 · Cited by 142
Research works printed but not linked: 4
- Riber, 2013, A novel glucagon analogue, ZP-GA-1, displays increased chemical and physical stability in liquid formulation, Diabetes, 62, A99
- Houston, 1996, Lactam bridge stabilization of alpha-helices: the role of hydrophobicity in controlling dimeric versus monomeric alpha-helices, Biochemistry, 35, 10041, 10.1021/bi952757m · doi:10.1021/bi952757m
- Fosgerau, 2011, The new glucagon-GLP-1 dual agonist ZP2929 in combination with long-acting insulin improves glycemic control without causing weight loss in db/db mice, Diabetes, 60, A408
- Just, 2014, The novel GLP-1-GLP-2 dual agonist ZP-GG-72 increases intestinal growth and improves insulin sensitivity in DIO mice, Diabetes, 63, A1
Cited by
Therapeutic Peptides: Current Applications and Future Directions
Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00904-4 · Cited by 2,131
Trends in peptide drug discovery
Muttenthaler, M., King, G. F., Adams, D. J., & Alewood, P. F. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-00135-8 · Cited by 1,964
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“However, therapeutic peptides have some significant drawbacks related to their stability and short half-life (123).”
BackgroundThe Current State of Peptide Drug Discovery: Back to the Future?
Henninot, A., Collins, J. C., & Nuss, J. M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00318 · Cited by 1,113
PEP-FOLD3: faster de novo structure prediction for linear peptides in solution and in complex
Lamiable, A., Thévenet, P., Rey, J., Vavrusa, M., Derreumaux, P., & Tufféry, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw329 · Cited by 1,053
Drugging the ‘undruggable’ cancer targets
Dang, C. V., Reddy, E. P., Shokat, K. M., & Soucek, L. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.36 · Cited by 927
“…oligonucleotides in nanoparticles 44 ), others are tweaking the ubiquitin system to hijack the degradation machinery and target specific cancer drivers 45 , and some are developing small and large peptides to interfere with PPIs and overcome the limitations of small interacting surfaces 46 .”
Sánchez, A., & Vázquez, A. (2017) · Food Quality and Safety · doi:10.1093/fqs/fyx006 · Cited by 868
Gadde, U., Kim, W. H., Oh, S. T., & Lillehoj, H. S. (2017) · Animal Health Research Reviews · doi:10.1017/s1466252316000207 · Cited by 796
Advances in Fmoc solid‐phase peptide synthesis
Behrendt, R., White, P., & Offer, J. (2016) · Journal of Peptide Science · doi:10.1002/psc.2836 · Cited by 760
A Comprehensive Review on Current Advances in Peptide Drug Development and Design
Lee, A. C.-L., Harris, J. L., Khanna, K. K., & Hong, J.-H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102383 · Cited by 686
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Alternatives to Conventional Antibiotics in the Era of Antimicrobial Resistance
Ghosh, C., Sarkar, P., Issa, R., & Haldar, J. (2019) · Trends in Microbiology · doi:10.1016/j.tim.2018.12.010 · Cited by 661
Amide Bond Bioisosteres: Strategies, Synthesis, and Successes
Kumari, S., Carmona, A. V., Tiwari, A. K., & Trippier, P. C. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00530 · Cited by 654
Unusual Amino Acids in Medicinal Chemistry
Blaskovich, M. A. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00319 · Cited by 635
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design
Li, J., Koh, J.-J., Liu, S., Lakshminarayanan, R., Verma, C. S., & Beuerman, R. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00073 · Cited by 611
HPEPDOCK: a web server for blind peptide–protein docking based on a hierarchical algorithm
Zhou, P., Jin, B., Li, H., & Huang, S.-Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky357 · Cited by 609
Residue-Specific Peptide Modification: A Chemist’s Guide
deGruyter, J. N., Malins, L. R., & Baran, P. S. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00536 · Cited by 573
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields
Moretta, A., Scieuzo, C., Petrone, A. M., Salvia, R., Manniello, M. D., Franco, A., Lucchetti, D., Vassallo, A., Vogel, H., Sgambato, A., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.668632 · Cited by 497
Nielsen, S. D., Beverly, R. L., Qu, Y., & Dallas, D. C. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.04.056 · Cited by 494
THPdb: Database of FDA-approved peptide and protein therapeutics
Usmani, S. S., Bedi, G., Samuel, J. S., Singh, S., Kalra, S., Kumar, P., Ahuja, A. A., Sharma, M., Gautam, A., & Raghava, G. P. S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181748 · Cited by 485
Gunassekaran, G. R., Poongkavithai Vadevoo, S. M., Baek, M.-C., & Lee, B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121137 · Cited by 483
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
Xiao, W., Jiang, W., Chen, Z., Huang, Y., Mao, J., Zheng, W., Hu, Y., & Shi, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02107-5 · Cited by 449
Edmondson, S. D., Yang, B., & Fallan, C. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.030 · Cited by 422
A Global Review on Short Peptides: Frontiers and Perspectives
Apostolopoulos, V., Bojarska, J., Chai, T.-T., Elnagdy, S., Kaczmarek, K., Matsoukas, J., New, R., Parang, K., Lopez, O. P., Parhiz, H., et al. (2021) · Molecules · doi:10.3390/molecules26020430 · Cited by 421
Biological metal–organic frameworks: Structures, host–guest chemistry and bio-applications
Cai, H., Huang, Y.-L., & Li, D. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.12.003 · Cited by 419
Sun, Y., Lau, S. Y., Lim, Z. W., Chang, S. C., Ghadessy, F., Partridge, A., & Miserez, A. (2022) · Nature Chemistry · doi:10.1038/s41557-021-00854-4 · Cited by 411
Antibiotic discovery: history, methods and perspectives
Durand, G. A., Raoult, D., & Dubourg, G. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.11.010 · Cited by 403
Current strategies for the design of PROTAC linkers: a critical review
Troup, R. I., Fallan, C., & Baud, M. G. J. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00018 · Cited by 424
“However, the highly polar peptidic ligase-binding sequences of these early PROTACs caused poor cell permeability, presented potential issues with their proteolytic stability, and consequently limited their therapeutic scope [19].”
BackgroundAntimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications
Deslouches, B., & Di, Y. P. (2017) · Oncotarget · doi:10.18632/oncotarget.16743 · Cited by 390
New Modalities for Challenging Targets in Drug Discovery
Valeur, E., Guéret, S. M., Adihou, H., Gopalakrishnan, R., Lemurell, M., Waldmann, H., Grossmann, T. N., & Plowright, A. T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611914 · Cited by 382
Intestinal permeation enhancers for oral peptide delivery
Maher, S., Mrsny, R. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.06.005 · Cited by 381
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor
Ge, X., Yang, H., Bednarek, M. A., Galon-Tilleman, H., Chen, P., Chen, M., Lichtman, J. S., Wang, Y., Dalmas, O., Yin, Y., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.016 · Cited by 376
“6 Cell Metabolism 27, 1–9, February 6, 2018 LEAP2 is rapidly cleared from the circulation (Figure S3G), which is generally the case for unmodified peptides (Fosgerau and Hoffmann, 2015).”
BackgroundAntimicrobial peptides under clinical investigation
Koo, H. B., & Seo, J. (2019) · Peptide Science · doi:10.1002/pep2.24122 · Cited by 376
Liquid‐Assisted Grinding Mechanochemistry in the Synthesis of Pharmaceuticals
Ying, P., Yu, J., & Su, W. (2021) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.202001245 · Cited by 368
ToxinPred2: an improved method for predicting toxicity of proteins
Sharma, N., Naorem, L. D., Jain, S., & Raghava, G. P. S. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac174 · Cited by 366
Mutant p53 as a target for cancer treatment
Duffy, M. J., Synnott, N. C., & Crown, J. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.06.023 · Cited by 364
Late‐Stage Peptide Diversification by Position‐Selective C−H Activation
Wang, W., Lorion, M. M., Shah, J., Kapdi, A. R., & Ackermann, L. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201806250 · Cited by 335
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Rayego-Mateos, S., Morgado-Pascual, J. L., Opazo-Ríos, L., Guerrero-Hue, M., García-Caballero, C., Vázquez-Carballo, C., Mas, S., Sanz, A. B., Herencia, C., Mezzano, S., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113798 · Cited by 334
Peptidomimetic toolbox for drug discovery
Lenci, E., & Trabocchi, A. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00102c · Cited by 326
Rapid and efficient protein synthesis through expansion of the native chemical ligation concept
Kulkarni, S. S., Sayers, J., Premdjee, B., & Payne, R. J. (2018) · Nature Reviews Chemistry · doi:10.1038/s41570-018-0122 · Cited by 323
ToxinPred 3.0: An improved method for predicting the toxicity of peptides
Rathore, A. S., Choudhury, S., Arora, A., Tijare, P., & Raghava, G. P. S. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108926 · Cited by 317
Peptide-based drug discovery: Current status and recent advances
Sharma, K., Sharma, K. K., Sharma, A., & Jain, R. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103464 · Cited by 313
Machine intelligence in peptide therapeutics: A next‐generation tool for rapid disease screening
Basith, S., Manavalan, B., Hwan Shin, T., & Lee, G. (2020) · Medicinal Research Reviews · doi:10.1002/med.21658 · Cited by 312
Protein-peptide docking: opportunities and challenges
Ciemny, M., Kurcinski, M., Kamel, K., Kolinski, A., Alam, N., Schueler-Furman, O., & Kmiecik, S. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.05.006 · Cited by 306
Aguirre, T. A. S., Teijeiro-Osorio, D., Rosa, M., Coulter, I. S., Alonso, M. J., & Brayden, D. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.004 · Cited by 299
Gaussian accelerated molecular dynamics: Principles and applications
Wang, J., Arantes, P. R., Bhattarai, A., Hsu, R. V., Pawnikar, S., Huang, Y. M., Palermo, G., & Miao, Y. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1521 · Cited by 295
Admassu, H., Gasmalla, M. A. A., Yang, R., & Zhao, W. (2018) · Journal of Food Science · doi:10.1111/1750-3841.14011 · Cited by 293
Peptidomimetic therapeutics: scientific approaches and opportunities
Qvit, N., Rubin, S. J. S., Urban, T. J., Mochly-Rosen, D., & Gross, E. R. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.11.003 · Cited by 273
Aminoacyl-tRNA synthetases as therapeutic targets
Kwon, N. H., Fox, P. L., & Kim, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0026-3 · Cited by 270
Antifungal Peptides as Therapeutic Agents
Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E., & Cotter, P. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00105 · Cited by 264
Zhou, M., Qian, Y., Xie, J., Zhang, W., Jiang, W., Xiao, X., Chen, S., Dai, C., Cong, Z., Ji, Z., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202000505 · Cited by 260
Molecular mechanism of VEGF and its role in pathological angiogenesis
Ahmad, A., & Nawaz, M. I. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30344 · Cited by 260
Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance
Manniello, M. D., Moretta, A., Salvia, R., Scieuzo, C., Lucchetti, D., Vogel, H., Sgambato, A., & Falabella, P. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03784-z · Cited by 259
Gal-Ben-Ari, S., Barrera, I., Ehrlich, M., & Rosenblum, K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00480 · Cited by 254
Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches
Brayden, D. J., Hill, T. A., Fairlie, D. P., Maher, S., & Mrsny, R. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.05.007 · Cited by 253
Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon
Srivastava, G., & Apovian, C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0300-4 · Cited by 232
The greening of peptide synthesis
Lawrenson, S. B., Arav, R., & North, M. (2017) · Green Chemistry · doi:10.1039/c7gc00247e · Cited by 205
Reappraisal of GIP Pharmacology for Metabolic Diseases
Finan, B., Müller, T. D., Clemmensen, C., Perez-Tilve, D., DiMarchi, R. D., & Tschöp, M. H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.005 · Cited by 180
Dairy bioactive proteins and peptides: a narrative review
Auestad, N., & Layman, D. K. (2021) · Nutrition Reviews · doi:10.1093/nutrit/nuab097 · Cited by 153
“identified, and the pharmaceutical industry had more than 60 peptide drugs on the market.(68) The recognition”
Zorzi, A., Middendorp, S. J., Wilbs, J., Deyle, K., & Heinis, C. (2017) · Nature Communications · doi:10.1038/ncomms16092 · Cited by 141
“eptides combine a range of favourable qualities such as suitable affinity and selectivity, low inherent toxicity, and access to chemical synthesis which make them an attractive modality for therapeutic development 1 .”
Practical Alkoxythiocarbonyl Auxiliaries for Iridium(I)‐Catalyzed C−H Alkylation of Azacycles
Tran, A. T., & Yu, J. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201704755 · Cited by 105
The Evolution of DNA-Templated Synthesis as a Tool for Materials Discovery
O’Reilly, R. K., Turberfield, A. J., & Wilks, T. R. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.7b00280 · Cited by 92
Cheang, J. Y., & Moyle, P. M. (2018) · ChemMedChem · doi:10.1002/cmdc.201700781 · Cited by 82
Gurung, S., Khan, F., Gunassekaran, G. R., Yoo, J. D., Poongkavithai Vadevoo, S. M., Permpoon, U., Kim, S.-H., Kim, H.-J., Kim, I.-S., Han, H., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119984 · Cited by 85
Garcia-Flores, V., Romero, R., Miller, D., Xu, Y., Done, B., Veerapaneni, C., Leng, Y., Arenas-Hernandez, M., Khan, N., Panaitescu, B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01291 · Cited by 71
Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide
Liu, B. H., Jobichen, C., Chia, C. S. B., Chan, T. H. M., Tang, J. P., Chung, T. X. Y., Li, J., Poulsen, A., Hung, A. W., Koh-Stenta, X., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801253115 · Cited by 67
Zhang, X., He, T., Chai, Z., Samulski, R. J., & Li, C. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.05.041 · Cited by 65
“Discussion 375 To date, increasing number of therapeutic pepti d s are used in a wide range of medical 376 applications [38].”
Backlund, C. M., Holden, R. L., Moynihan, K. D., Garafola, D., Farquhar, C., Mehta, N. K., Maiorino, L., Pham, S., Iorgulescu, J. B., Reardon, D. A., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2204078119 · Cited by 61
Research progress in calcitonin gene-related peptide and bone repair
Wang, Q., Qin, H., Deng, J., Xu, H., Liu, S., Weng, J., & Zeng, H. (2023) · Biomolecules · doi:10.3390/biom13050838 · Cited by 58
Revolutionizing peptide‐based drug discovery: Advances in the post‐AlphaFold era
Chang, L., Mondal, A., Singh, B., Martínez‐Noa, Y., & Perez, A. (2024) · WIREs Computational Molecular Science · doi:10.1002/wcms.1693 · Cited by 56
“8,9 Early on, peptides faced challenges concerning their short half-lives and high renal clearance.”
BackgroundA collagen‐binding EGFR single‐chain Fv antibody fragment for the targeted cancer therapy
Liang, H., Li, X., Chen, B., Wang, B., Zhao, Y., Zhuang, Y., Shen, H., Zhang, Z., & Dai, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.04.029 · Cited by 54
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
Mercer, D. K., & O'Neil, D. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02177 · Cited by 50
Ynamide‐Mediated Peptide Bond Formation: Mechanistic Study and Synthetic Applications
Xu, S., Jiang, D., Peng, Z., Hu, L., Liu, T., Zhao, L., & Zhao, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202212247 · Cited by 46
An estrogen receptor α-derived peptide improves glucose homeostasis during obesity
Yang, W., Jiang, W., Liao, W., Yan, H., Ai, W., Pan, Q., Brashear, W. A., Xu, Y., He, L., & Guo, S. (2024) · Nature Communications · doi:10.1038/s41467-024-47687-6 · Cited by 38
“Peptides have gained an increased interest in pharmaceutical researchduetotheirhighspeci fi city,ef fi ciency,andsafety 37 .”
Neuropeptide systems and new treatments for nicotine addiction
Bruijnzeel, A. W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4513-5 · Cited by 36
Protein–Protein Interaction Modulators for Epigenetic Therapies
(2018) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2017.06.002 · Cited by 31
Peptide design through binding interface mimicry with PepMimic
(2025) · doi:10.1038/s41551-025-01507-4 · Cited by 30
Biscaglia, F., Quarta, S., Villano, G., Turato, C., Biasiolo, A., Litti, L., Ruzzene, M., Meneghetti, M., Pontisso, P., & Gobbo, M. (2019) · Materials Science and Engineering: C · doi:10.1016/j.msec.2019.109762 · Cited by 25
Villard, J., Kılıç, M., & Rothlisberger, U. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c01078 · Cited by 19
AAontology: An Ontology of Amino Acid Scales for Interpretable Machine Learning
Breimann, S., Kamp, F., Steiner, H., & Frishman, D. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168717 · Cited by 15
Lin, H., Zhu, C., Shang, T., Zhu, N., Lin, K., Zhang, C., Shao, X., Wang, X., & Duan, H. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00896 · Cited by 10
HighMPNN: A Graph Neural Network Approach for Structure-Constrained Cyclic Peptide Sequence Design
Xu, W., Zhang, C., Shang, T., Mao, Q., Guo, J., & Duan, H. (2026) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3620163 · Cited by 8
Goldney, J., & Davies, M. J. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00977-2 · Cited by 7
Newkirk, S. E., Kelly, J. J., Hourn, N., Bhandari, S., Spencer, N., & Pires, M. M. (2026) · ACS Chemical Biology · doi:10.1021/acschembio.6c00291 · Cited by 2
Metadata
- Authors
- Fosgerau, K., & Hoffmann, T.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 20
- Issue
- 1
- Pages
- 122-128
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W1992450378
- Cited by
- 3,030
- References
- 24
- FWCI
- 55.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.